References
- Goldstein J L, Brown M S. The low density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 1977; 46: 897–930
- Brown M S, Goldstein J L. Lipoprotein metabolism in macrophage: Implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 1983; 52: 223–61
- Goldstein J L, Ho Y K, Basu K S, Brown M S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natn Acad Sci USA 1979; 76: 333–7
- Fogelman A, Schecter I, Seager J, Hokom M, Child J S, Edwards P A. Malondialdehyde alteration of low density lipoprotein leads to cholesterol ester accumulation in human monocyte-macrophages. Proc Natn Acad Sci USA 1980; 77: 2214–8
- Henriksen T, Mahoney E M, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoprotein. Proc Natn Acad Sci USA 1981; 78: 6499–503
- Pittman R C, Carew Th E, Glass C K, Green S R, Taylor C A, Attie A D. A radioiodinated in-tracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J 1983; 212: 791–800
- Henriksen T, Evensen S A, Elgjo R F, Vefling A. Human fetal endothelial cells in culture. Scand J Haematol 1975; 14: 233–41
- Tolleshaug H, Berg T, Nilsson M, Norum K R. Uptake and degradation of 125I-labelled asialofe-tuin by isolated rat hepatocytes. Biochim Biophys Acta 1977; 499: 73–84
- Nilsson M, Berg T. Uptake and degradation of formaldehyde treated 125I-labelled human serum albumin in rat liver cell in vivo and in vitro. Biochim Biophys Acta 1977; 497: 171–82
- Berg T, Boman D. Distribution of lysosomal enzymes between parenchymal and Kupffer cells in rat liver. Biochim Biophys Acta 1973; 321: 585–96
- Blomhoff R, Holte K, Næss L, Berg T. Newly administered 3H retinol is transferred from hepatocytes to stellate cells in liver storage. Exp Cell Res 1984; 150: 186–93
- Blomhoff R, Rasmussen M, Nilsson A, Norum K R, Berg T, Blaner W S, Kato M. Hepatic Retinol Metabolism. J Biol Chem 1985; 260: 13560–5
- Lowry O H, Rosenbrough N J, Farr A L, Randall R J. Protein measurement with Folin reagent. J Biol Chem 1951; 265–75
- Henriksen T, Mahoney E M, Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 1983; 3: 149–59
- Henriksen T, Mahoney E M, Steinberg D. Interactions of plasma lipoproteins with endothelial cells. Ann N Y Acad Sci 1982; 401: 102–16
- Steinbrecher U P, Parthasarathy S, Leake D, Witzum J L. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natn Acad Sci USA 1984; 82: 3883–7
- Mahley R W, Weisgraber K H, Innerarity T L, Windmueller H G. Accelerated clearance of low and high density lipoproteins and retarded clearance of E apoprotein counting lipoproteins from plasma of rats after modifications of lysin residues. Proc Natn Acad Sci USA 1979; 76: 1746–50
- Nagelkerke J F, Havekes L, Hinsbergh V WM, Van Berkel Th JC. In vivo catabolism of biologically modified LDL. Arterisclerosis 1984; 4: 256–64
- Kovanen P T, Faust J R, Brown M S, Goldstein J L. Low density lipoprotein receptors in bovine adrenal cortex. I. Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured adrenocortical cells. 1979; 104: 599–609
- Pitas R E, Boyles J, Mahley R W, Bissel D M. Uptake of chemically modified low density lipoprotein in vivo in mediated by specific endothelial cells. J Cell Biol 1985; 100: 113–7
- Blomhoff R, Drevon C A, Eskild W, Helgerud P, Norum K R, Berg T. Clearance of acetylated low density lipoprotein by rat liver endothelial cells. J Biol Chem 1984; 259: 8898–903
- Blomhoff R, Eskild W, Berg T. Endocytosis of formaldehyde treated albumin via scavenger pathway in liver endothelial cells. Biochem J 1984; 218: 81–6